The short answer: Cytoreductive surgery, also called debulking surgery, is the main operation for advanced ovarian cancer. The surgeon tries to remove all the cancer that can be seen, because women who have no visible cancer left after surgery usually do better. It is usually considered when ovarian cancer has spread inside the abdomen (stage 3, sometimes stage 4). Whether it is done before or after chemotherapy, and how large the operation is, depends on your scans, where the cancer has spread and how fit you are for a major operation. It is not right for everyone.
Families often search for this in Hindi as अंडाशय के कैंसर का ऑपरेशन (andashay ke cancer ka operation). Our main page explains cytoreductive surgery step by step; this page focuses on when and why it is needed.
On this page
- What Is Cytoreductive Surgery?
- Why Complete Cytoreduction Matters
- What the Surgery Involves
- Primary vs. Interval Cytoreduction
- When Is It Needed, and Who May Be Considered?
- Is HIPEC Always Added?
- Risks of the Operation
- Preparation and Recovery
What Is Cytoreductive Surgery?
Cytoreductive surgery — also called debulking surgery — is the surgical removal of as much tumour as possible from the abdominal and pelvic cavity. In ovarian cancer, the goal is to leave no visible residual disease (complete cytoreduction, or R0). This is not a simple hysterectomy — it is a complex, multi-organ procedure that may involve removal of the uterus, ovaries, omentum, peritoneum, appendix, sections of bowel, spleen, and even parts of the diaphragm.
The extent is different for each woman. A list of possible steps does not mean every patient needs all of them; the planned operation should be explained to you before you consent. For the wider picture, read our guide to ovarian cancer diagnosis and treatment.
Why Complete Cytoreduction Matters
The amount of cancer left behind after surgery (residual disease) is one of the most important factors in how women with advanced ovarian cancer do. Large reviews of many studies have found that women with no visible cancer left after surgery (complete cytoreduction) live longer, on average, than women left with visible disease. This is why the training and experience of the surgical team matter. The team aims for complete removal only when it can be done with an acceptable level of risk.
What the Surgery Involves
A typical cytoreductive procedure for advanced ovarian cancer may include some or all of the following:
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy
- Infragastric omentectomy
- Pelvic and para-aortic lymphadenectomy
- Peritoneal stripping (pelvic sidewalls, paracolic gutters, diaphragm)
- Rectosigmoid resection (if the recto-uterine pouch is involved)
- Splenectomy (if splenic hilum disease is present)
- Appendicectomy
- Liver surface resection
This is not a procedure that a general gynaecologist is trained to perform. Cytoreductive surgery for ovarian cancer requires a fellowship-trained gynaecological oncosurgeon working within a multidisciplinary team that includes colorectal surgeons, anaesthesiologists with oncology experience, and intensive care support.
Primary vs. Interval Cytoreduction
Primary cytoreduction means surgery first, soon after diagnosis, followed by chemotherapy. Interval cytoreduction means chemotherapy first (neoadjuvant chemotherapy), usually about 3 cycles, then surgery, then the remaining cycles. Chemotherapy first can shrink the cancer and may make complete removal safer when the disease is very extensive or when a patient needs time to become fitter.
Reviews of randomised trials have found similar survival with either order for women who are suitable for both, with fewer serious surgical complications and fewer stomas when chemotherapy comes first. Neither order is better for everyone; the choice depends on your scans, where the cancer is, your fitness and the team’s assessment. Read more about how chemotherapy fits into treatment.
When Is It Needed, and Who May Be Considered?
Cytoreductive surgery is usually considered when:
- ovarian, fallopian-tube or peritoneal cancer has spread to the lining of the abdomen (peritoneum) or the fatty apron over the bowel (omentum), as in stage 3 and some stage 4 cancers;
- scans and specialist assessment suggest that all visible cancer can be removed safely, either now or after a few cycles of chemotherapy;
- you are fit enough for a major operation, or can be helped to become fitter first.
In selected women whose cancer comes back after a long gap, a second operation (secondary cytoreduction) may be discussed; this is decided case by case. Surgery may not be the right choice when the cancer cannot be removed safely or when general health makes a long operation too risky. Chemotherapy, other medicines or care focused on symptoms may then be better options.
Is HIPEC Always Added?
No. HIPEC (heated chemotherapy washed through the abdomen during surgery, sometimes called garam chemo) is added only for selected women, mostly with stage 3 (sometimes stage 4) cancer, when all visible tumour can be removed and the patient is fit. The strongest evidence is for surgery after chemotherapy (interval surgery). With HIPEC, the operation usually takes 8–14 hours and the hospital stay is about 10–14 days, including 3–5 days in the ICU. It is not a guaranteed cure. Read more about HIPEC surgery.
Advanced ovarian cancer is usually operated on through an open cut, because several areas of the abdomen may need treatment. Robotic or keyhole surgery is not used for this operation, although keyhole surgery may help assess the disease in selected cases.
Risks of the Operation
Because it can involve several organs, cytoreductive surgery carries real risks. These depend on how much surgery is needed and may include bleeding, infection, blood clots, chest problems, a leak where the bowel is joined, a temporary or permanent stoma (an opening of the bowel on the tummy), and the need for intensive care. Your surgeon should explain the risks that apply to you before you consent.
Preparation and Recovery
Before surgery, the team reviews your scans, biopsy, CA-125 and other blood tests, and checks your heart, lungs and nutrition. You may be advised to walk daily, do breathing exercises and improve your diet. As a general guide after major cytoreductive surgery, the hospital stay is about 10–14 days, gentle daily activity returns in about 4–6 weeks, and full recovery takes about 3–4 months. Chemotherapy usually continues once you have recovered enough. These are averages, not promises; the team should give you an individual plan.
For a consultation about cytoreductive surgery for ovarian cancer in Ahmedabad, contact Dr. Nishtha Tripathi Patel: +91 76988 00333.